FindTrial
Sign In

Construction and empirical evaluation of drug therapy management model for heart failure based on SPMDC theory

Construction and empirical evaluation of drug therapy management model for heart failure based on SPMDC theory

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097109
Enrollment
Unknown
Registered
2025-02-12
Start date
2025-03-03
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Intervention group:Drug therapy management of heart failure based on SPMDC theory
Traditional management group:Patients are managed in a traditional way

Sponsors

The 2nd Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Age >18 years old; 2.Diagnosis of heart failure, heart function I-IV.

Exclusion criteria

Exclusion criteria: 1.Autoimmune disease; 2.Long-term use of immunosuppressants, NSAIDS drugs; 3.contraindications for drug treatment of heart failure, such as significant bradycardia (heart rate < 45/ min), cardiogenic shock, sick sinus syndrome, grade II-III atrioventricular block (no pacemaker installed); 4.Pregnant woman;

Design outcomes

Primary

MeasureTime frame
Heart failure readmission rate;all-cause mortality;—

Secondary

MeasureTime frame
medication adherence (MMAS-8 score);Heart failure mortality;quality of life (MLHFQ);all-cause readmission rate;Cardiac color ultrasound;NT-proBNP;Expense consumption;Blood routine examination;renal function;Liver function;Blood pressure;—

Countries

China

Contacts

Public ContactNa Wang

The 2nd Affiliated Hospital of Chongqing Medical University

lena731@sina.com+86 13594036081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026